Lack of evidence that adherence to standard of care therapy improves survival in subjects with hepatocellular carcinoma in clinical practice

Publisher： John Wiley & Sons Inc

E-ISSN： 1096-9071|87|8|1368-1376

ISSN： 0146-6615

Source： JOURNAL OF MEDICAL VIROLOGY, Vol.87, Iss.8, 2015-08, pp. : 1368-1376

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Functional and Clinical Evidence That TAZ is a Candidate Oncogene in Hepatocellular Carcinoma

By  

JOURNAL OF CELLULAR BIOCHEMISTRY, Vol. 116, Iss. 11, 2015-11 ,pp. : 2465-2475

John Wiley & Sons Inc

Access to resources Recommend Favorite

A Surgical Perspective on Targeted Therapy of Hepatocellular Carcinoma

By Faltermeier Claire   Busuttil Ronald W.   Zarrinpar Ali  

Diseases, Vol. 3, Iss. 4, 2015-09 ,pp. : 221-252

MDPI

Access to resources Recommend Favorite

New Tools for Molecular Therapy of Hepatocellular Carcinoma

By Marchetti Alessandra   Bisceglia Francesca   Cozzolino Angela M.   Tripodi Marco  

Diseases, Vol. 3, Iss. 4, 2015-10 ,pp. : 325-340

MDPI

Access to resources Recommend Favorite

Hepatocellular Carcinoma: Past and Future of Molecular Target Therapy

By Nguyen Khanh   Jack Kerri   Sun Weijing  

Diseases, Vol. 4, Iss. 1, 2015-12 ,pp. : 1-1

MDPI

Access to resources Recommend Favorite

Tumor Microenvironment, a Paradigm in Hepatocellular Carcinoma Progression and Therapy

By Tahmasebi Birgani Maryam   Carloni Vinicio  

International Journal of Molecular Sciences, Vol. 18, Iss. 2, 2017-02 ,pp. : 405-405

MDPI

Access to resources Recommend Favorite